Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-02

Clinical Trial Update: Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives [Phase 2]

View source ↗

Summary

Phase 2 trial comparing continuous versus interrupted oral contraceptives for menstrually related disorders was terminated. Results were posted on 2017-01-02.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combined oral contraceptives

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Premenstrual Syndrome, PMS | Phase 2 | Status: TERMINATED | Results posted: 2017-01-02